Dopamine produced by the stomach may act as a paracrine/autocrine hormone in the rat

Neuroendocrinology

Volumn 67, Issue 5, 1998, Pages 336-348

  Mezey, Éva ^a   Eisenhofer, Graeme ^a   Hansson, Stefan ^b   Hunyady, Béla ^b,c   Hoffman, Beth J ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Catecholamines; Monoamine transporters; Parietal cells; Peripheral neuroendocrinology; Stomach; Sympathectomy

Indexed keywords

CARRIER PROTEIN; DOPA; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE TRANSPORTER; MESSENGER RNA; MONOAMINE; NEUROHORMONE; RECEPTOR SUBTYPE; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; DOPAMINE UPTAKE; DUODENUM; GASTROINTESTINAL TRACT; HISTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEUROSECRETORY CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; STOMACH EPITHELIUM; STOMACH JUICE; STOMACH PARIETAL CELL; STOMACH PROTECTION;

ANIMALS; AUTOCRINE COMMUNICATION; BIOLOGICAL TRANSPORT; CATECHOLAMINES; DOPAMINE; GASTRIC JUICE; MALE; PARACRINE COMMUNICATION; PARIETAL CELLS, GASTRIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; STOMACH; TYROSINE 3-MONOOXYGENASE;

EID: 0031981233     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054332     Document Type: Article

References (88)

1. Glavin G, Szabó S: Dopamine in gastrointestinal disease. Dig Dis Sci 1990;35:1153-1161.
2. Glavin GB, Murison R, Overmier JB, Pare WP, Bakke HK, Henke PG, Hernandez DE: The neurobiology of stress ulcers. Brain Res Rev 1991;16:301-343.
3. Glavin D, Dugani A: Effects of dopamine agonists and antagonists on gastric acid secretion and stress responses in stress. Life Sci 1987;41: 1397-1408.
4. Flemström G, Safsten B: Role of dopamine and other stimuli of mucosal bicarbonate secretion in duodenal protection. Dig Dis Sci 1994;39: 1839-1842.
5. MacNaughton WK, Wallace JL: A role for dopamine as an endogenous protective factor in the rat stomach. Gastroenterology 1989;96: 972-980.
6. Sikiric P, Rotkvic I, Mise S, Petek M, Rucman R, Seiwerth S, Zjacic-Rotkvic V, Duvnjak M, Jagic V, Suchanek E, Grabarevic Z, Anic T, Brkic T, Djermanovic Z, Dodig N, Marovic A, Hernandez DE: Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. Dig Dis Sci 1991;36:905-910.
7. Szabó S: Dopamine disorder in duodenal ulceration. Lancet 1979;ii:880-882.
8. Szabó S, Sandrock AW, Nafradi J, Maull EA, Gallagher GT, Blyzniuk A: Dopamine and dopamine receptors in the gut: Their possible role in duodenal ulceration; in Kohsaka M (ed): Advances in Dopamine Research. Oxford, Pergamon Press, 1982, pp 165-170.
9. Häggendal J: The presence of dopamine in human gastric juice. Acta Physiol Scand 1967; 71:127-128.
10. Christensen NJ, Brandsborg O: Dopamine in human gastric juice determined by a sensitive double-isotope-derivative technique. Scand J Clin Lab Invest 1974;34:315-320.
11. Glavin GB: Activity of selective dopamine DA1 and DA2 agonists and antagonists on experimental gastric lesions and gastric acid secretion. J Pharmacol Exp Ther 1989;251: 726-730.
12. Strang R: The association of gastro-duodenal ulceration and Parkinson's disease. Med J Aust 1965;1:842-843.
13. Edwards LL, Quigley EM, Pfeiffer RF: Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology (see comments). Neurology 1992;42:726-732.
14. Samet ET, White MS, Vaugh AM: Duodenal ulcer in a patient with schizophrenia. Am J Dig Dis 1957;2:437-441.
15. Pollak OJ, Kreplick F: Peptic ulcers in the insane. Clinical and postmortem study. J Nerv Ment Dis 1945;101:1-8.
16. Graffner H, Ekelund M, Hakanson R, Oscarson J, Rosengren E, Sundler F: Effects of upper abdominal sympathectomy on gastric acid, serum gastrin, and catecholamines in the rat gut. Scand J Gastroenterol 1984;19:711-716.
17. Kawakita N, Nagahata Y, Saitoh Y: Immunohistochemical study of dopamine in rat gastric mucosa with acute gastric ulcer. J Gastroenterol 1994;29:695-702.
18. Mosin VI, Agranovich NV, Gudzovskii AG: Dopamine levels in the gastric and duodenal mucosa, blood and urine in patients with duodenal ulcer. Ter Arkh 1987;59:18-22.
19. Nishizaki Y: The effects of exogenous and endogenous dopamine on the gastric microcirculation and their action sites in rat stomach. Nippon Shokakibyo Gakkai Zasshi 1993;90: 1639-1651.
20. Hakanson R: New aspects of the formation and function of histamine, 5-hydroxytryptamine and dopamine in the gastric mucosa. Acta Physiol Scand 1970;340(suppl):1-134.
21. Larsson LI: Gastrointestinal cells producing endocrine, neurocrine and paracrine messengers. Clin Gastroenterol 1980;9:485-516.
22. Schultzberg M, Hokfelt T, Nilsson G, Terenius L, Rehfeld JF, Brown M, Elde R, Goldstein M, Said S: Distribution of peptide- and catecholamine-containing neurons in the gastrointestinal tract of rat and guinea-pig: Immunohistochemical studies with antisera to substance P, vasoactive intestinal polypeptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin and dopamine beta-hydroxylase. Neuroscience 1980;5:689-744.
23. Bäck N, Ahonen M, Soinila S, Kivilaakso E, Kiviluoto T: Catecholamine-synthesizing enzymes in the rat stomach. Histochem Cell Biol 1995;104:63-67.
24. Graffner H, Ekelund M, Hakanson R, Rosengren E: Effect of different denervation procedures on catecholamines in the gut. Scand J Gastroenterol 1985;20:1276-1280.
25. Favre-Maurice R, de Haut M, Dalmaz Y, Peyrin L: Differential effect of guanethidine on dopamine and norepinephrine in rat peripheral tissues. J Neural Transm Gen Sect 1992;88: 115-126.
26. Orloff LA, Orloff MS, Bunnett NW, Walsh JH: Dopamine and norepinephrine in the alimentary tract changes after chemical sympathectomy and surgical vagotomy. Life Sci 1985;36: 1625-1631.
27. Cannata B, Figueroa E, Aguero E, Peralta H, Suarez JR: Study of gastric secretion in rats with ligation of the pylorus according to the Shay and Dai methods. Acta Gastroenterol Latinoam 1977;7:43-46.
28. Chayvialle JA, Lambert R, Ruet D: Effect of esophageal ligation on gastric secretion in rats with pyloric ligation. Biol Gastroenterol (Paris) 1972;5:127-134.
29. Mozsik G, Karsai T, Teichmann F: Alterations in stomach wall glycoproteins during gastric ulceration induced by pyloric ligation. Digestion 1972;5:253-260.
30. Stockhaus K, Wick H: Modification of gastric juice secretion by saliva of rats with pyloric ligation (Shay rats). Arzneimittelforschung 1970;20:858-861.
31. Steinbusch HW, Wouterlood FG, de Vente J, Bol JG, Berkenbosch F: Immunohistochemical localization of monoamines and cyclic nucleotides. Their application in quantitative immunofluorescence studies and tracing monoaminergic neuronal connections. Acta Histochem Suppl 1988;35:86-106.
32. Quansah FA, Klatt C, Feldman JM: Effects of diabetes mellitus and chemical sympathectomy on tissue monamine oxidase activity and norepinephrine concentration in the golden hamster. Metabolism 1981;30:242-247.
33. Eisenhofer G, Goldstein D, Stull R, Keiser H, Sunderland T, Murphy D, Kopin I: Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenyl-glycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma and their responses to inhibition of monoamine oxidase. Clin Chem 1986;32: 2030-2033.
34. Naoi M, Takahashi T, Nagatsu T: Simple assay procedure for tyrosine hydroxylase activity by high-performance liquid chromatography employing colorometric detection with minimal sample preparation. J Chromatogr 1988;427: 229-238.
35. Berghorn KA, Bonnett JH, Hoffman GE: cFos immunoreactivity is enhanced with biotin amplification. J Histochem Cytochem 1994;42: 1635-1642.
36. Hunyady B, Krempels K, Harta G, Mezey E: Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostainings. J Histochem Cytochem 1966;44:1353-1362.
37. Bradley DJ, Towle HC, Young WS: Spatial and temporal expression of alpha- and beta-thyroid hormone receptor mRNAs, including the beta 2-subtype, in the developing mammalian nervous system. J Neurosci 1992;12;2288-2302.
38. Grima B, Lamouroux A, Blanot F, Biguet NF, Mallet J: Complete coding sequence of rat tyrosine hydroxylase mRNA. Proc Natl Acad Sci USA 1985;82:617-621.
39. Monsma FJ, Mahan LC, McVittie LD, Gerfen CR, Sibley DR: Molecular cloning and expression of a D1 receptor linked to adenylyl cyclase activation. Proc Natl Acad Sci USA 1990;87: 6723-6727.
40. Tiberi M, Jarvie KR, Silvia C, Falardeau P, Gingrich JA, Godinot N, Bertrand L, Yang-Feng TL, Fremeau RTJ, Caron MG: Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D-1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. Proc Natl Acad Sci USA 1991; 88:7491-7495.
41. Gerfen C, Engber T, Mahan L, Susel Z, Chase T, Monsma FJ, Sibley D: D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990; 253:332.
42. Sokoloff P, Giros B, Martres MP, Bouthenet ML, Schwartz JC: Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 1990;347: 146-151.
43. Van Tol HHM, Bunzow JR, Guan HC, Sunahara RK, Seeman P, Niznik HB, Civelli O: Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 1991;350:610-614.
44. Kilty JE, Lorang D, Amara SG: Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 1991;254:578-579.
45. Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH: A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 1992;70: 539-551.
46. Erickson JD, Eiden LE, Hoffman BJ: Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc Natl Acad Sci USA 1992;89:10993-10997.
47. Young WSI: Simultaneous use of digoxigeninand radiolabeled oligodeoxyribonucleotide probes for hybridization histochemistry. Neuropeptides 1989;13:271-275.
48. Smith P, Krohn R, Hermanson G, Mallia A, Gartner F, Provenzano M, Fujimoto E, Goeke N, Olson B, Klenk D: Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150:76-85.
49. Glavin GB, Hall AM: Brain-gut relationships: Gastric mucosal defense is also important. Acta Physiol Hung 1992;80:107-115.
50. Valenzuela JE: Dopamine as a possible neurotransmitter in gastric relaxation. Gastroenterology 1976;71:1019-1022.
51. Schuurkes JA, Van Nueten JM: Gastric relaxation induced by peri-arterial (sympathetic?) electrical stimulation in vitro. Scand J Gastroenterol Suppl 1984;89:49-53.
52. Mersereau WA, Hinchey EJ: Role of gastric mucosal folds in formation of focal ulcers in the rat. Surgery 1982;91:150-155.
53. Munch G, Raether A, Schoffel E, Illes P: Post-synaptic dopamine DA1- and DA2-receptors in jejunal arteries of rabbits. J Cardiovasc Pharmacol 1991;18:468-471.
54. Kullmann R, Breull WR, Wassermann K, Konopatzki A: Blood flow redistribution by dopamine in the feline gastrointestinal tract. Naunyn Schmiedebergs Arch Pharmacol 1983;323: 145-148.
55. Kullmann R, Breull WR, Reinsberg J, Wassermann K, Konopatzki A: Dopamine produces vasodilation in specific regions and layers of the rabbit gastrointestinal tract. Life Sci 1983; 32:2115-2122.
56. Germann R, Hasibeder W, Luz G: Effect of low-dose dopamine on gut ischemia in a porcine model of hemorrhagic shock (letter; comment). J Appl Physiol 1993;74:1472-1473.
57. Germann R, Haisjackl M, Hasibeder W, Sparr H, Luz G, Plattner R, Pernthaler H, Friesenecker B, Falk M: Dopamine and mucosal oxygenation in the porcine jejunum. J Appl Physiol 1994;77:2845-2852.
58. Lambalgen A v, Kraats A v, Mulder MF, Bos D v, Teerlink T, Thijs LG: Organ blood flow and distribution of cardiac output in dopexamine- or dobutamine-treated endotoxemic rats. J Crit Care 1993;8:117-127.
59. Schmidt H, Secchi A, Wellmann R, Bach A, Bhrer H, Martin E: Dopexamine maintains intestinal villus blood flow during endotoxemia in rats. Crit Care Med 1996;24:1233-1237.
60. Karzai W, Gunnicker M, Scharbert G, Vorgrimler-Karzai UM, Priebe HJ: Effects of dopamine on oxygen consumption and gastric mucosal blood flow during cardiopulmonary bypass in humans. Br J Anaesth 1996;77:603-606.
61. Kaise M, Echizen H, Ishizaki T: Dopaminergic control of gastric mucosal blood flow in humans. A study with endoscopic laser Doppler flowmetry coupled with gastric submucosal drug injection. Dig Dis Sci 1993;38:1169-1174.
62. 99mTc-4-methylaminophenazone clearance technique. Acta Med Hung 1987;44:157-180.
63. Flemström G, Safsten B, Jedstedt G: Stimulation of mucosal alkaline secretion in rat duodenum by dopamine and dopaminergic compounds. Gastroenterology 1993;104:825-833.
64. Knutson L, Knutson TW, Flemstrom G: Endogenous dopamine and duodenal bicarbonate secretion in humans. Gastroenterology 1993; 104:1409-1413.
65. Andersen PH: The dopamine inhibitor GBR 12909: Selectivity and molecular mechanism of action. Eur J Pharmacol 1989;166:493-504.
66. Glavin GB: A dopamine D3 receptor agonist, 7-hydroxy-N,N-di-n-propyl-2-aminotetralin, reduces gastric acid and pepsin secretion and experimental gastric mucosal injury in rats. Life Sci 1995;56:287-293.
67. Glavin GB: Central antisecretory and peripheral gastroprotective effects of GBR 12909, a selective dopamine uptake inhibitor. Life Sci 1994;55:PL451-PL454.
68. Szabo S: Experimental basis for a role for sulfhydryls and dopamine in ulcerogenesis: A primer for cytoprotection-organoprotection. Klin Wochenschr 1986;64(suppl 7):116-122.
69. Majno PE, Licker M, Kadry Z, Buhler L, Morel DR, Morel P: Effect of dopamine, norepinephrine, and prostaglandin-E1 on graft perfusion in small bowel transplantation in pigs. Transplant Proc 1996;28:2549-2550.
70. Iwatsuki K, Homma T, Malik KU: Contribution of prostaglandins to dopamine actions in the pancreas of anesthetized dogs. Am J Physiol 1985;248:G110-G117.
71. Eisenhofer G, Aneman A, Friberg P, Hooper D, Fandriks L, Lonroth H, Hunyady B, Mezey E: Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab 1997;82:3864-3871.
72. Håkanson R: New aspects of the formation and function of histamine, 5-hydroxytryptamine and dopamine in gastric mucosa. Acta Physiol Scand 1970;340(suppl):1-134.
73. Borowsky B, Hoffman BJ: Neurotransmitter transporters: Molecular biology, function and regulation; in Bradley RJ, Harris RA (eds): International Review of Neurobiology. San Diego, Academic Press, 1995, pp 139-199.
74. Peter D, Liu Y, Sternini C, de Giorgio R, Brecha N, Edwards RH: Differential expression of two vesicular monoamine transporters. J Neurosci 1995;15:6179-6188.
75. Liu Y, Schweitzer ES, Nirenberg MJ, Pickel VM, Evans CJ, Edwards RH: Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells. J Cell Biol 1994;127:1419-1433.
76. Glavin GB: Dopamine DA1 receptor activation reduces experimentally-induced gastritis in rats. Gen Pharmacol 1993;24:1481-1842.
77. Glavin GB, Hall AM: Central and peripheral dopamine D1/DA1 receptor modulation of gastric secretion and experimental gastric mucosal injury. Gen Pharmacol 1995;26:1277-1279.
78. Germann R, Hasibeder W, Haisjackl M, Sparr H, Luz G, Pernthaler H, Friesenecker B, Bonatti J, Gruber E, Schwarz B: Dopamine-1-receptor Stimulation and mucosal tissue oxygenation in the porcine jejunum. Crit Care Med 1995;23:1560-1566.
79. Ziller C, Mirabel MA, Vandenbunder B, Fauquet M: The tyrosine hydroxylase gene is expressed in endoderm and pancreas of early quail embryos. Anat Embryol 1994;189:307-315.
80. Arluison M, Dietl M, Thibault J: Ultrastructural morphology of dopaminergic nerve terminals and synapses in the striatum of the rat using tyrosine hydroxylase immunocytochemistry: A topographical study. Brain Res Bull 1984;13:269-285.
81. Dietl M, Arluison M, Mouchet P, Feuerstein C, Manier M, Thibault J: Immunohistochemical demonstration of catecholaminergic cell bodies in the spinal cord of the rat. Preliminary note. Histochemistry 1985;82:385-389.
82. Chiodo LA, Kapatos G: Membrane properties of identified mesencephalic dopamine neurons in primary dissociated cell culture. Synapse 1992;11:294-309.
83. Rohrer H, Acheson AL, Thibault J, Thoenen H: Developmental potential of quail dorsal root ganglion cells analyzed in vitro and in vivo. J Neurosci 1986;6:2616-2624.
84. Vaughan RA: Photoaffinity-labeled ligand binding domains on dopamine transporters identified by peptide mapping. Mol Pharmacol 1995;47:956-964.
85. Caffe AR, van Leeuwen FW, Buijs RM, de Vries GJ, Geffard M: Coexistence of vasopressin, neurophysin and noradrenaline immunoreactivity in medium-sized cells of the locus coeruleus and subcoeruleus in the rat. Brain Res 1985;338:160-164.
86. Smolka A, Swiger KM: Site-directed antibodies as topographical probes of the gastric H,K-ATPase alpha-subunit. Biochim Biphys Acta 1992;1108:75-85.
87. Schafer MKH, Nahr D, Romeo H, Eiden LE, Weihe E: Pan-neuronal expression of chromogranin A in rat nervous system. Peptides 1994; 15:263-279.
88. Harris J, Ayyub C, Shaw G: A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF-M and NF-H. J Neurosci Res 1991;30:47-62.